Jan 5 (Reuters) - Compass Pathways PLC CMPS.O :
* COMPASS PATHWAYS AND GREENBROOK TMS ENTER INTO THREE-YEAR
RESEARCH COLLABORATION AGREEMENT
* THREE-YEAR RESEARCH COLLABORATION AGREEMENT TO EXPLORE
DELIVERY
MODELS FOR INVESTIGATIONAL COMP360 PSILOCYBIN TREATMENT
* COMPASS HAS COMMENCED A PHASE 3 CLINICAL PROGRAM OF
COMP360 IN
TRD
* COMPASS INTENDS TO APPLY FOR FDA APPROVAL UPON COMPLETION
OF
CLINICAL TRIALS.
Source text for Eikon: ID:nGNX4fDZyN
Further company coverage: CMPS.O
((Reuters.Briefs@thomsonreuters.com;))